Efficacy and safety of ixekizumab in a phase III, randomized, double-blind, placebo-controlled study in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS). (Record no. 30882503)

MARC details
000 -LEADER
fixed length control field 01689 a2200493 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518100112.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202105s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1365-2133
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1111/bjd.19147
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Paller, A S
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20210514
245 00 - TITLE STATEMENT
Title Efficacy and safety of ixekizumab in a phase III, randomized, double-blind, placebo-controlled study in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS).
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The British journal of dermatology
Date of publication, distribution, etc. 08 2020
300 ## - PHYSICAL DESCRIPTION
Extent 231-241 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Child
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dermatologic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Etanercept
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Psoriasis
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quality of Life
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Severity of Illness Index
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Seyger, M M B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Alejandro Magariños, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bagel, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pinter, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cather, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Keller, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rodriguez Capriles, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gontijo Lima, R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gallo, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Little, C A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Edson-Heredia, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Li, L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Xu, W
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Papp, K
773 0# - HOST ITEM ENTRY
Title The British journal of dermatology
Related parts vol. 183
-- no. 2
-- p. 231-241
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1111/bjd.19147">https://doi.org/10.1111/bjd.19147</a>
Public note Available from publisher's website

No items available.